ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2015 American Transplant Congress

    Recreational Marijuana Use Is Not Associated With Worse Kidney Allograft Outcomes

    G. Greenan, M. Anders, A. Leeser, J. Bromberg, S. Niederhaus.

    Department of Surgery, University of Maryland, Baltimore, MD; Department of Anesthesiology, University of Maryland, Baltimore, MD; Department of Surgery, University of Maryland, Baltimore, MD; Department of Surgery, University of Maryland, Baltimore, MD; Department of Surgery, University of Maryland, Baltimore, MD.

    Background: As marijuana (MJ) legalization is ongoing, kidney transplant programs need to develop listing criteria for MJ users. No data exist on whether recreational MJ…
  • 2015 American Transplant Congress

    The Potential of E-Health to Improve Adherence: Exploring the Patients' View

    D. Slaats,1 M. Tielen,1 M. Laging,1 T. van Gelder,2 W. Weimar,1 E. Massey.1

    1Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2Internal Medicine and Hospital Pharmacology, Erasmus MC, Rotterdam, Netherlands.

    Introduction. Transplant outcomes can be negatively influenced by medication nonadherence. Therefore, there is a need for effective interventions to improve adherence. In recent years due…
  • 2015 American Transplant Congress

    Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes

    A. Alvarado,1 A. Shetty,1 O. Traitanon,1 J. Leventhal,1 V. Mas,2 D. Chhabra,3 J. Matthews,1 L. Gallon.1

    1Comprehensive Transplant Center, Northwestern University, Chicago, IL; 2University of Virgina, Charlottesville, Va; 3Advocate Christ Medical Center, Chicago, IL.

    We previously reported the short-term feasibility of Calcineurin-Inhibitor (CNI) elimination in kidney transplant recipients. We now report the long-term clinical impact on renal allograft function…
  • 2015 American Transplant Congress

    Rejection Triggers Liver Transplant Tolerance: Involvement of Mesenchyma-Meidated Immune Control Mechanisms

    M. Morita, D. Joyce, C. Miller, J. Fung, L. Lu, S. Qian.

    Immunology, Lerner Research Institute; 2General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

    Successful organ transplantation relies on lifelong immunosuppression, associated with severe side effects. Induction of tolerance is ideal but elusive in clinic. Indeed spontaneous liver transplant…
  • 2015 American Transplant Congress

    Final Results from the BENEFIT-EXT Trial: A 7 Year Follow-Up of Belatacept Treated Patients

    S. Florman,1 J. Medina Pestana,2 M. Rial,3 L. Rostaing,4 D. Kuypers,5 F. Mühlbacher,6 M. Polinsky,7 U. Meier-Kriesche,7 J. Grinyó,8 A. Durrbach.9

    1Mt Sinai Med Ctr, NY; 2Hosp do Rim e Hipertensão, Sao Paulo, Brazil; 3Inst de Nefrologia, Buenos Aires, Argentina; 4Univ Hospital, Toulouse, France; 5Univ Hospital Leuven, Leuven, Belgium; 6Vienna Transplantation Ctr, Vienna, Austria; 7BMS, Lawrenceville; 8Univ Hosp Bellvitge, Barcelona, Spain; 9Univ Hosp of Bicêtre, Villejuif, France.

    Background: At 3 and 5yrs post-transplant, BENEFIT-EXT showed a renal function benefit and consistent safety in belatacept (bela) treated pts vs cyclosporine (CsA). Final 7…
  • 2015 American Transplant Congress

    Notch-1 Inhibition Promotes Immune Regulation in Solid Organ Transplantation

    C. Magee,1 M. Ohari,1 T. Shimizu,1 S. Ohori,1 N. Najafian,2 L. Riella.1

    1Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston; 2Cleveland Clinic, Weston.

    Notch receptor signaling plays a key role in T cell activation and differentiation, though limited data exist on its importance in immune regulation. Herein, we…
  • 2015 American Transplant Congress

    Body Mass Index (BMI) Mismatch in Deceased Kidney Donation Is an Independent Risk Factor for Graft Failure

    O. Staeck,1 D. Khadzhynov,1 M. Mahn,2 K. Budde,1 F. Fuller,2 F. Halleck.1

    1Nephrology, Charite Universitaetsmedizin, Berlin, Germany; 2Urology, Charite Universitaetsmedizin, Berlin, Germany.

    IntroductionThe influence of this BMI-mismatch in deceased kidney donors and their recipients on graft survival is so far not well characterized.MethodsRetrospective long-term observational study of…
  • 2015 American Transplant Congress

    Renal Resistance Measured During Pulsatile Perfusion and Long-Term Kidney Transplant Outcomes

    S. Sandal, R. Sapir-Pichhadze, M. Cantarovich, S. Paraskevas.

    McGill University Health Center, Montreal, QC, Canada.

    Background: Pulsatile perfusion (PP) has been shown to reduce the incidence of delayed graft function (DGF) and increase short- and long-term kidney transplant (KT) survival.…
  • 2015 American Transplant Congress

    Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers

    D. Hoyer,1 A. Gallinat,1 T. Minor,2 F. Saner,1 P. Kocabayoglu,1 J. Treckmann,1 A. Paul.1

    1General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Surgical Research Division, University Hospital Bonn, Bonn, Germany.

    Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…
  • 2015 American Transplant Congress

    Donor CD47 Plays a Critical Role in the Control of Alloreactive T Cell Activation Following Hepatocyte Transplantation

    M. Zhang,1,2 H. Wang,1 N. Navarro-Alvarez,1 Y. Zheng,2 Y.-G. Yang.1

    1Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY; 2First Hospital, Jilin University, Changchun, Jilin, China.

    Background: The interspecies incompatibility of CD47 is an important mechanism triggering rejection of cellular xenografts, including both hematopoietic and non-hematopoietic cells, by recipient macrophages. Our…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences